Reply to Chu et al., “Adoption of the New CLSI Fluoroquinolone Breakpoints for Enterobacteriaceae”
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Microbiology"
DOI: 10.1128/jcm.01268-19
Abstract: We thank Chu and colleagues ([10][1]) for highlighting the potential impact of the 2019 revised Clinical and Laboratory Standards Institute (CLSI) Enterobacteriaceae fluoroquinolone breakpoints on the reporting of other members of this antibiotic class, in… read more here.
Keywords: clsi; reply chu; fluoroquinolone breakpoints; chu adoption ... See more keywords